The intervention leads to lower blood‐feeding success (unwashed nets) (high certainty).
The intervention leads to lower blood‐feeding success (washed nets) (high certainty).
The intervention probably leads to higher mosquito mortality (unwashed nets) (moderate certainty).
Impact of Xpert MTB/RIF showed no clear difference in all‐cause mortality among participants compared with smear microscopy (moderate certainty).
Impact of Xpert MTB/RIF showed no clear difference in all‐cause mortality at 6 months (subgroup) compared with smear microscopy (moderate certainty).
Impact of Xpert MTB/RIF showed no clear difference in successful treatment outcome in participants treated for tuberculosis compared with smear microscopy (moderate certainty).
Impact of Xpert MTB/RIF showed no clear difference in proportion of participants who were treated for tuberculosis compared with smear microscopy (moderate certainty).
Impact of Xpert MTB/RIF probably leads to lower pre‐treatment loss to compared with smear microscopy (moderate certainty).
Impact of Xpert MTB/RIF probably leads to higher treated participants with bacteriological confirmation of tuberculosis compared with smear microscopy (moderate certainty).
It is very uncertain whether ivermectin changes incidence of clinical malaria compared with control (very low certainty).
It is very uncertain whether ivermectin changes adverse events compared with control (very low certainty).
Rapid susceptibility methods showed no clear difference in mortality compared with standard methods versus placebo (low certainty).
Rapid susceptibility methods showed no clear difference in mortality (subgroup genotypic) compared with standard methods versus placebo (low certainty).
Rapid susceptibility methods showed no clear difference in mortality (subgroup phenotypic) compared with standard methods versus placebo (low certainty).
Rapid susceptibility methods showed no clear difference in mortality (with stewardship) compared with standard methods versus placebo (low certainty).
Rapid susceptibility methods showed no clear difference in mortality (without stewardship) compared with standard methods versus placebo (low certainty).
Hydroxychloroquine (HCQ) showed no clear difference in death due to any cause compared with standard care or placebo (high certainty).
Hydroxychloroquine (HCQ) probably leads to higher participants with any adverse events compared with placebo (moderate certainty).